These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor. Gmeiner M; Zimpfer D; Holfeld J; Seebacher G; Abraham D; Grimm M; Aharinejad S J Thorac Cardiovasc Surg; 2011 May; 141(5):1238-45. PubMed ID: 21329947 [TBL] [Abstract][Full Text] [Related]
5. Angiogenic gene-modified myoblasts promote vascularization during repair of skeletal muscle defects. Zhou W; He DQ; Liu JY; Feng Y; Zhang XY; Hua CG; Tang XF J Tissue Eng Regen Med; 2015 Dec; 9(12):1404-16. PubMed ID: 23365046 [TBL] [Abstract][Full Text] [Related]
6. Transplantation of novel vascular endothelial growth factor gene delivery system manipulated skeletal myoblasts promote myocardial repair. Zhu K; Guo C; Xia Y; Lai H; Yang W; Wang Y; Song D; Wang C Int J Cardiol; 2013 Oct; 168(3):2622-31. PubMed ID: 23578891 [TBL] [Abstract][Full Text] [Related]
8. Angiogenic Growth Factors for Coronary Artery Disease: Current Status and Prospects. Guo M; Shi JH; Wang PL; Shi DZ J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):130-141. PubMed ID: 29025278 [TBL] [Abstract][Full Text] [Related]
9. Cell transplantation for heart disease: the clinical perspective. Yang S; Fazel S; Angoulvant D; Weisel RD; Li RK Evid Based Cardiovasc Med; 2005 Mar; 9(1):2-7. PubMed ID: 16379977 [No Abstract] [Full Text] [Related]
10. Vascular endothelial growth factor transgene expression in cell-transplanted hearts. Yau TM; Li G; Weisel RD; Reheman A; Jia ZQ; Mickle DA; Li RK J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1180-7. PubMed ID: 15052220 [TBL] [Abstract][Full Text] [Related]
11. Biological properties of human skeletal myoblasts genetically modified to simultaneously overexpress the pro-angiogenic factors vascular endothelial growth factor-A and fibroblast growth factor-4. Zimna A; Janeczek A; Rozwadowska N; Fraczek M; Kucharzewska P; Rucinski M; Mietkiewski T; Kurpisz M J Physiol Pharmacol; 2014 Apr; 65(2):193-207. PubMed ID: 24781729 [TBL] [Abstract][Full Text] [Related]
12. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy. Memon IA; Sawa Y; Miyagawa S; Taketani S; Matsuda H J Thorac Cardiovasc Surg; 2005 Sep; 130(3):646-53. PubMed ID: 16153908 [TBL] [Abstract][Full Text] [Related]
13. Scaffold-based transplantation of vascular endothelial growth factor-overexpressing stem cells leads to neovascularization in ischemic myocardium but did not show a functional regenerative effect. von Wattenwyl R; Blumenthal B; Heilmann C; Golsong P; Poppe A; Beyersdorf F; Siepe M ASAIO J; 2012; 58(3):268-74. PubMed ID: 22543757 [TBL] [Abstract][Full Text] [Related]
14. Gene transfer of connexin43 into skeletal muscle. Reinecke H; Minami E; Virag JI; Murry CE Hum Gene Ther; 2004 Jul; 15(7):627-36. PubMed ID: 15242523 [TBL] [Abstract][Full Text] [Related]
15. Novel hyperbranched polyamidoamine nanoparticles for transfecting skeletal myoblasts with vascular endothelial growth factor gene for cardiac repair. Zhu K; Guo C; Lai H; Yang W; Xia Y; Zhao D; Wang C J Mater Sci Mater Med; 2011 Nov; 22(11):2477-85. PubMed ID: 21870080 [TBL] [Abstract][Full Text] [Related]